Novavax's Covid Vaccine May Pinch, But the Charts Really Hurt
Shares of Novavax are looking weak and in need of a booster, according to the technicals.
My Strategy to Buy Beam Therapeutics
Let's look at the charts and indicators.
Humana's Charts Look Healthy and Headed Higher
The technical setup of the healthcare provider's stock is bullish.
GoodRx Stock Looks Ready to Be Priced Like a Generic Drug
The charts don't look promising for GDRX.
Peloton Still Forgets How to Ride a Bike
The shares took another hit today after sinking the past 12 months.
This Options Play Is Just What the Doctor Ordered
Here's my trade prescription for Medical Properties Trust, an under-the-radar Real Estate Investment Trust.
Moderna Stock Continues to Build a New Base Pattern
With the shares rallying, let's check how the charts are doing.
Privia Health's Charts Look Promising
The technical history of the stock is limited but buyers appear more aggressive than sellers.
I Don't Trust CVS Health's Stock: Here's When I Get Out
I have no patience moving forward with a large firm standing on a sloppy book, trying to digest an acquisition it needs to make, but can only questionably afford.
I've Got a Rough Floorplan for How to Play Blueprint Medicines
The charts for this drug developer are starting to take shape.